Henry W. Pauls

1.9k citations

44 papers · 943 indexed · h-index 17

Molecular Biology
Organic Chemistry top 5%
Hematology top 5%
Computational Theory and Mathematics top 5%
Cardiology and Cardiovascular Medicine

Co-authors: William R. Ewing Bert Fraser‐Reid Alfred P. Spada Yong Mi Choi-Sledeski Michael R. Becker J.P. Guilloteau S. Maignan Vincent Mikol
Topics: Blood Coagulation and Thrombosis Mechanisms (14 papers)Carbohydrate Chemistry and Synthesis (8 papers)Chemical Synthesis and Analysis (7 papers)
Cited by: Hematology Molecular Medicine Organic Chemistry
Journals: Journal of the American Chemical Society Cancer Research Journal of Medicinal Chemistry
Partner nations: United States Canada France

In The Last Decade

Henry W. Pauls

43 papers receiving 880 citations

Peers

Countries citing papers authored by Henry W. Pauls

Since Specialization

Citations

This map shows the geographic impact of Henry W. Pauls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry W. Pauls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry W. Pauls more than expected).

Fields of papers citing papers by Henry W. Pauls

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry W. Pauls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry W. Pauls. The network helps show where Henry W. Pauls may publish in the future.

Co-authorship network of co-authors of Henry W. Pauls

This figure shows the co-authorship network connecting the top 25 collaborators of Henry W. Pauls. A scholar is included among the top collaborators of Henry W. Pauls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry W. Pauls. Henry W. Pauls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vitroactivity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics 2013 ·Journal of Chemotherapy ·Nachum Kaplan,Donald E. Awrey,(unknown),Judd Berman,Jeremy A. Yethon,Henry W. Pauls,Barry Hafkin	29
2	Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor 2012 ·Antimicrobial Agents and Chemotherapy ·Nachum Kaplan,Monique Albert,Donald E. Awrey,(unknown),Judd Berman,Teresa E. Clarke,(unknown),Barry Hafkin,(unknown),V. Romanov,Molly B. Schmid,(unknown),Jeremy A. Yethon,Henry W. Pauls	92
3	Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent 2011 ·Bioorganic & Medicinal Chemistry Letters ·Guyan Liang,Suzanne C. Aldous,(unknown),Julian Levell,(unknown),Jennifer Cairns,Xin Chen,S. Maignan,Magali Mathieu,(unknown),(unknown),Sam Rebello,(unknown),Isabelle Morize,Henry W. Pauls	16
4	Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI) 2009 ·Bioorganic & Medicinal Chemistry Letters ·Peter B. Sampson,Christine J. Picard,(unknown),(unknown),(unknown),Andrew Leeson,V. Romanov,Donald E. Awrey,(unknown),(unknown),Nachum Kaplan,Judd Berman,Henry W. Pauls	17
5	Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase 2005 ·Bioorganic & Medicinal Chemistry Letters ·Corey R. Hopkins,(unknown),Steven S. Kaye,(unknown),(unknown),Henry W. Pauls,Guyan Liang,(unknown),(unknown),Jennifer Cairns,(unknown),(unknown),(unknown),Sam Rebello,(unknown),A. Dupuy,Magali Mathieu,Julian Levell	29
6	Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation 2004 ·Bioorganic & Medicinal Chemistry Letters ·Corey R. Hopkins,Kent Neuenschwander,(unknown),Sharon Jackson,Thaddeus R. Nieduzak,Henry W. Pauls,Guyan Liang,(unknown),(unknown),Jennifer Cairns,S. Maignan,Magali Mathieu	20
7	Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Scott I. Klein,Kevin R. Guertin,(unknown),Allison L. Zulli,Henry W. Pauls,Alfred P. Spada,Daniel L. Cheney,Karen Brown,Dennis Colussi,Valeria Chu,Robert J. Leadley,Christopher T. Dunwiddie	14
8	Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity 2002 ·Bioorganic & Medicinal Chemistry Letters ·Kevin R. Guertin,(unknown),Scott I. Klein,Allison L. Zulli,(unknown),Yong Gong,Alfred P. Spada,Daniel L. Cheney,(unknown),J.P. Guilloteau,Karen Brown,Dennis Colussi,Valeria Chu,Christopher L. Heran,(unknown),Ross Bentley,Christopher T. Dunwiddie,Robert J. Leadley,Henry W. Pauls	45
9	The Design of Competitive, Small-molecule Inhibitors of Coagulation Factor Xa 2001 ·Current Topics in Medicinal Chemistry ·Henry W. Pauls,William R. Ewing	27
10	Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa 2000 ·Bioorganic & Medicinal Chemistry Letters ·Yong Gong,Henry W. Pauls,Alfred P. Spada,(unknown),Guyan Liang,Valeria Chu,Dennis Colussi,Karen Brown,Jingbo Gao	9
11	Solid-phase parallel synthesis of azarene pyrrolidinones as factor Xa inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Yong Gong,Michael R. Becker,Yong Mi Choi-Sledeski,(unknown),Joseph M. Salvino,Valeria Chu,Karen Brown,Henry W. Pauls	13
12	In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737 2000 ·Thrombosis Research ·Valeria Chu,Karen Brown,Dennis Colussi,(unknown),Dan Green,Henry W. Pauls,Alfred P. Spada,Mark H. Perrone,Robert J. Leadley,Christopher T. Dunwiddie	16
13	Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·Michael R. Becker,William R. Ewing,(unknown),Henry W. Pauls,Cuong Q. Ly,(unknown),Helen J. Mason,Yong Mi Choi-Sledeski,Alfred P. Spada,Valeria Chu,Karen Brown,Dennis Colussi,Robert J. Leadley,Ross Bentley,(unknown),Charles Kasiewski,(unknown)	19
14	Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa 1999 ·Journal of Cardiovascular Pharmacology ·Robert J. Leadley,(unknown),Ross Bentley,Jeffrey S. Bostwick,Charles Kasiewski,Christopher L. Heran,Valeria Chu,Karen Brown,(unknown),William R. Ewing,Henry W. Pauls,Alfred P. Spada,Mark H. Perrone,Christopher T. Dunwiddie	15
15	Aminoisoquinolines: Design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA 1999 ·Bioorganic & Medicinal Chemistry Letters ·Yong Mi Choi-Sledeski,Michael R. Becker,(unknown),(unknown),William R. Ewing,Helen J. Mason,Cuong Q. Ly,(unknown),Guyan Liang,Daniel L. Cheney,(unknown),Valeria Chu,Karen Brown,Dennis Colussi,Ross Bentley,Robert J. Leadley,Christopher T. Dunwiddie,Henry W. Pauls	20
16	Characterization of the bisphosphonate recognition site on hydroxyapatite using radioligand binding techniques with [14C]citric acid 1993 ·Calcified Tissue International ·Michael F. Jarvis,Carol J. Burns,Henry W. Pauls,(unknown),(unknown),Daniel L. Cheney,Raymond D. Youssefyeh	10
17	Irreversible Inhibition of Transglutaminases by Sulfonium Methylketones: Optimization of Specificity and Potency with w-Aminoacyl Spacers 1992 ·Journal of enzyme inhibition ·Diana H. Pliura,(unknown),Henry W. Pauls,(unknown),Allen Krantz	13
18	New inhibitors of cysteine proteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge strategy 1988 ·Journal of the American Chemical Society ·Roger A. Smith,Leslie J. Copp,Peter J. Coles,Henry W. Pauls,Valerie J. Robinson,Robin W. Spencer,Stephen B. Heard,Allen Krantz	53
19	Stereocontrolled routes to cis-hydroxyamino sugars. Part VI. A synthesis of garosamine 1984 ·Canadian Journal of Chemistry ·Henry W. Pauls,Bert Fraser‐Reid	10
20	An efficient synthesis of ristosamine utilizing the allylic hydroxyl of a hex-2-enopyranoside 1983 ·The Journal of Organic Chemistry ·Henry W. Pauls,Bert Fraser‐Reid	24

About Henry W. Pauls

Henry W. Pauls is a scholar working on Hematology, Molecular Medicine and Organic Chemistry, having authored 44 papers that have together received 943 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Chemical Synthesis and Analysis (7 papers). The work is most often cited by research in Hematology (215 citations), Molecular Medicine (80 citations) and Organic Chemistry (368 citations). Henry W. Pauls has collaborated with scholars based in United States, Canada and France. Frequent co-authors include William R. Ewing, Bert Fraser‐Reid, Alfred P. Spada, Yong Mi Choi-Sledeski, Michael R. Becker, J.P. Guilloteau, S. Maignan, Vincent Mikol, Scott I. Klein and Valeria Chu. Their work appears in journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact